NeuroScientific Biopharmaceuticals Limited

NeuroScientific Biopharmaceuticals Limitedverified

NSB.AX

Price:

$0.105

Market Cap:

$34.92M

NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. The company was incorporated in 2002 and is based in Cottesloe, Australia.

Industry

Biotechnology

IPO Date

2018-07-27

Stock Exchange

ASX

Ticker

NSB.AX

The ROE as of December 2025 (TTM) for NeuroScientific Biopharmaceuticals Limited (NSB.AX) is -16.93%

According to NeuroScientific Biopharmaceuticals Limited’s latest financial reports and current stock price. The company's current ROE is -16.93%. This represents a change of 249.11% compared to the average of -4.85% of the last 4 quarters.

NeuroScientific Biopharmaceuticals Limited (NSB.AX) Historical ROE (quarterly & annually)

How has NSB.AX ROE performed in the past?

The mean historical ROE of NeuroScientific Biopharmaceuticals Limited over the last ten years is -60.85%. The current -16.93% ROE has changed -72.17% with respect to the historical average. Over the past ten years (40 quarters), NSB.AX's ROE was at its highest in in the June 2023 quarter at 42.42%. The ROE was at its lowest in in the December 2017 quarter at -153.87%.

Quarterly (TTM)
Annual

Average

-60.85%

Median

-40.76%

Minimum

-189.05%

Maximum

6.06%

NeuroScientific Biopharmaceuticals Limited (NSB.AX) ROE by Quarter and Year

Discovering the peaks and valleys of NeuroScientific Biopharmaceuticals Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 768.76%

Maximum Annual ROE = 6.06%

Minimum Annual Increase = -Infinity%

Minimum Annual ROE = -189.05%

Quarterly (TTM)
Annual
YearROEChange
2025-10.98%-281.13%
20246.06%-126.61%
2023-22.77%-87.95%
2022-189.05%768.76%
2021-21.76%-72.32%
2020-78.62%139.84%
2019-32.78%-74.22%
2018-127.15%160.91%
2017-48.74%-41.11%
2016-82.75%-Infinity%

NeuroScientific Biopharmaceuticals Limited (NSB.AX) Average ROE

How has NSB.AX ROE performed in the past?

The current ROE of NeuroScientific Biopharmaceuticals Limited (NSB.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-9.23%

5-year avg

-47.70%

10-year avg

-60.85%

NeuroScientific Biopharmaceuticals Limited (NSB.AX) ROE vs. Peers

How is NSB.AX’s ROE compared to its peers?

NeuroScientific Biopharmaceuticals Limited’s ROE is greater than Prescient Therapeutics Limited (-54.17%), greater than Proteomics International Laboratories Limited (-76.33%), greater than AnteoTech Limited (-82.51%), greater than Radiopharm Theranostics Limited (-74.91%), greater than Cynata Therapeutics Limited (-107.51%), less than Doctor Care Anywhere Group PLC (857.22%), greater than Argenica Therapeutics Limited (-70.19%), greater than Amplia Therapeutics Limited (-38.89%), greater than Next Science Limited (-491.26%), greater than Noxopharm Limited (-194.85%),

Build a custom stock screener for NeuroScientific Biopharmaceuticals Limited (NSB.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroScientific Biopharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuroScientific Biopharmaceuticals Limited (NSB.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuroScientific Biopharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is NeuroScientific Biopharmaceuticals Limited's ROE?

How is the ROE calculated for NeuroScientific Biopharmaceuticals Limited (NSB.AX)?

What is the highest ROE for NeuroScientific Biopharmaceuticals Limited (NSB.AX)?

What is the 3-year average ROE for NeuroScientific Biopharmaceuticals Limited (NSB.AX)?

What is the 5-year average ROE for NeuroScientific Biopharmaceuticals Limited (NSB.AX)?

How does the current ROE for NeuroScientific Biopharmaceuticals Limited (NSB.AX) compare to its historical average?